Bovine leukemia virus
This article includes a list of references, but its sources remain unclear because it has insufficient inline citations. (September 2017) (Learn how and when to remove this template message)
|Bovine leukemia virus|
|Group:||Group VI (ssRNA-RT)|
|Species:||Bovine leukemia virus|
Bovine leukemia virus (BLV) is a retrovirus which causes enzootic bovine leukosis in cattle. It is closely related to the human T‑lymphotropic virus type 1 (HTLV-I). BLV may integrate into the genomic DNA of B‑lymphocytes as a DNA intermediate (the provirus), or exist as unintegrated circular or linear forms. Besides structural and enzymatic genes required for virion production, BLV contains an oncogene coding for a protein called Tax and expresses microRNAs of unknown function. In cattle, most infected animals are asymptomatic; leukemia is rare (about 5% of infected animals), but lymphoproliferation is more frequent (30%).
Disease in cattle
Many potential routes of BLV transmission exist. Transmission through procedures that transmit blood between animals such as gouge dehorning, vaccination and ear tagging with instruments or needles that are not changed or disinfected between animals is a significant means of BLV spread. Rectal palpation with common sleeves poses a risk that is increased by inexperience and increased frequency of palpation. Transmission via colostrum, milk, and in utero exposure is generally considered to account for a relatively small proportion of infections. Embryo transfer and artificial insemination also account for a small number of new infections if common equipment and/or palpation sleeves are used. While transmission has been documented via blood feeding insects, the significance of this risk is unclear. Transmission relies primarily on the transfer of infected lymphocytes from one animal to the next, and BLV positive animals with lymphocytosis are more likely to provide a source for infection. Virus particles are difficult to detect and not used for transmission of infection.
In general, BLV causes only a benign mononucleosis-like disease in cattle. Only some animals later develop a B-cell leukemia called enzootic bovine leukosis. Under natural conditions the disease is transmitted mainly by milk to the calf.
The variety of organs where white blood cells occur explains the many symptoms: enlargement of superficial lymph nodes, a digestive form, a cardiac form, a nervous form, a respiratory form, and others. Lymph node enlargement is often an early clinical sign. An unexpected clinical finding is protrusion of the conjunctival membrane, due to enlargement of retro-ocular lymph nodes.
BLV infection in humans can be identified by testing for antibodies against BLV using the immunoblotting and searching for antibodies against the purified recombinant p24 capsid protein. This protein acts as an antigen for the IgG antibodies.
Treatment and control
No apparent treatment is available for the disease. Testing and removing positive animals from the herd is one method of control. In herds where the disease is widespread, it is important to limit spread by avoiding contact with blood between animals.
Epidemiology and eradication efforts
In Europe attempts were made to eradicate the virus by culling infected animals. The first country considered to be free of infection was Denmark. Soon the United Kingdom followed. Like the North American states, those of the Eastern block in Europe did not try to get rid of the virus. But the Eastern Europe states started to become leukosis free after the political changes at the end of the last century. A quote from a USDA fact sheet, "The high individual animal prevalence of BLV reported in the Dairy 1996 study suggests that testing and culling seropositive animals may not be a cost effective method to control the disease. Instead, preventing disease transmission by implementing preventive practices would likely be more cost-effective."
High prevalence of virus was found from testing by USDA. "As part of the 2007 dairy study, bulk tank milk was collected from 534 operations with 30 or more dairy cows and tested with an Enzyme Linked-Immunosorbent Assay (ELISA) for the presence of antibodies against BLV. Results showed that 83.9 percent of U.S. dairy operations were positive for BLV (table 1)." BLV infection can be detected by ELISA or PCR.
Potential infection in humans
Because the oncogenic properties of the virus were discovered early on, a search for evidence of pathogenicity in humans started soon after discovery. Several studies have been carried out to determine whether BLV causes disease in humans, testing mostly farm workers who drink raw milk from infected cows. Some long term studies may be necessary, as there appears to be a correlation in instances of cancer among butchers and slaughterhouse workers. It was discovered in 2003 that some humans carry antibodies reactive to BLV. In 2014, researchers discovered the presence of BLV positive cells in the human breast tissue. A case-control study published in 2015 suggests a that exposure to BLV is associated with breast cancer. A later study of Australian women detected retrotranscribed BLV DNA in breast tissue of 40/50(80%) of women with breast cancer versus 19/46(41%) of women with no history of breast cancer, indicating an age-adjusted odds ratio and confidence interval of 4.72(1.71-13.05). These results corroborate the findings of the previous study of US women with an even higher odds ratio for the Australian population. Most recently a case-control study of Texas women established an association between BLV presence in breast tissue and breast cancer status with an odd ratio OR 5.1.
However, more recently, another case-control study conducted on Chinese patients did not find any association between BLV and breast cancer. A subsequent evaluation of the Chinese study pointed out weaknesses in methodology used, e.g. a veterinary test kit designed and calibrated for cattle inappropriately used to test for human antibodies, despite warnings against this in kit instructions. An exhaustive analysis of 51 whole genomes of breast cancers did not show any trace of BLV DNA and thus excludes clonal insertion (integration into human genomic DNA) of BLV in breast tumor cells. However, this search for BLV in breast tumor cells did not target unintegrated BLV DNA that could be associated with breast cancer.
Infection in other species
Natural infection of animals other than cattle and buffalo are rare, although many animals are susceptible to artificial infection. After artificial infection of sheep most animals succumb to leukemia. Rabbits get a fatal AIDS-like disease similar to Pasteurella, different from the benign human snuffles. It is not known whether this naturally occurring rabbit disease is linked to BLV infection. "Although several species can be infected by inoculation of the virus, natural infection occurs only in cattle (Bos taurus and Bos indicus), water buffaloes, and capybaras. Sheep are very susceptible to experimental inoculation and develop tumours more often and at a younger age than cattle. A persistent antibody response can also be detected after experimental infection in deer, rabbits, rats, guinea-pigs, cats, dogs, sheep, rhesus monkeys, chimpanzees, antelopes, pigs, goats and buffaloes."
Because of the close relationship between BLV and HTLV-I, the research on BLV is important. One can use the experience with BLV for understanding HTLV-I induced diseases like ATL (adult T-cell leukemia) and HAM/TSP (HTLV-1-associated myelopathy/Tropical spastic paraparesis)-like neurological disorders. A number of case-control studies have been conducted, however the research in BLV related diseases is not as extensive as with other virus related diseases.
Researchers have been working on developing an attenuated provirus vaccine for bovine. The theory is to create a provirus with a deletion in the pathogenic gene that confers oncogenesis (tax). This vaccine would be able to induce a persistent anti-BLV immune response through maintaining a low level of infectivity, while preventing the risk of infection by the wild-type virus which maintains the ability to drive oncogenesis. However, attempts thus far have not been able to create a vaccine that is easily transmitted from mother to offspring.
- Reyes, R.A.; Cockerell, G.L. (August 1996). "Unintegrated bovine leukemia virus DNA: Association with viral expression and disease" (PDF). Journal of Virology. 70 (8): 4961–4965. PMC . PMID 8764001.
- Nicolas Rosewick; Mélanie Momont; Keith Durkin; Haruko Takeda; Florian Caiment; Yvette Cleuter; Céline Vernin; Franck Mortreux; Eric Wattel; Arsène Burny; Michel Georges & Anne Van den Broeke (2013). "Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma". Proceedings of the National Academy of Sciences. 110 (6): 2306–11. doi:10.1073/pnas.1213842110. PMC . PMID 23345446.
- Meas, Sothy; Usui, Tatsufumi; Ohashi, Kazuhiko; Sugimoto, Chihiro; Onuma, Misao (2002-01-23). "Vertical transmission of bovine leukemia virus and bovine immunodeficiency virus in dairy cattle herds". Veterinary Microbiology. 84 (3): 275–282. doi:10.1016/s0378-1135(01)00458-8. PMID 11731179.
- Mahy, Brian W.J. (2009). "Bovine leukemia virus". The dictionary of virology (4th ed.). Amsterdam: Elsevier/Academic Press. pp. 61–62. ISBN 9780080920368.
- D.C. Blood; J.A. Henderson; O.M. Radostits (1979). Veterinary Medicine (5th ed.). London: Baillière Tindall. pp. 611 (Leucosis in cattle and other species). ISBN 0-7020-0718-8.
- Bovine Leukaemia Virus reviewed and published by WikiVet, accessed 10 October 2011.
- Buehring, Gertrude C.; Shen, Hua Min; Jensen, Hanne M.; Choi, K. Yeon; Sun, Dejun; Nuovo, Gerard (1 May 2014). "Bovine leukemia virus DNA in human breast tissue". 20 (5): 772–782. doi:10.3201/eid2005.131298.
- OIE (2010). "Chapter 2.4.11 Enzootic bovine leukosis" (PDF). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. World Organisation for Animal Health (OIE).
- "Bovine Leukosis Virus on U.S. Dairy Operations, 2007" (PDF). NAHMS Dairy 2007. U.S. Department of Agriculture.
- Buehring GC, Philpott SM, Choi KY (December 2003). "Humans have antibodies reactive with Bovine leukemia virus". AIDS Res. Hum. Retroviruses. 19 (12): 1105–13. doi:10.1089/088922203771881202. PMID 14709247.
- Johnson ES (2005). "Assessing the role of transmissible agents in human disease by studying meat workers". Cellscience Reviews. 2 (1). ISSN 1742-8130. Archived from the original on 2006-10-18.
- Buehring, Gertrude C.; Shen, Hua Min; Jensen, Hanne M.; Jin, Diana L.; Hudes, Mark; Block, Gladys (2 September 2015). "Exposure to bovine leukemia virus is associated with breast cancer: A case-control study". PLoS ONE. 10 (9). doi:10.137/journal.pone.0134304.
- Buehring, Gertrude C.; Shen, Hua Min; Schwartz, Daniel A.; Lawson, James S.; Coleman, William B. (22 June 2017). "Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development". PLOS ONE. 12 (6): e0179367. doi:10.1371/journal.pone.0179367.
- Buehring, Gertrude C.; Nuovo, Gerard J.; Sison, Jennette D.; Krishnamurty, Savitri; Shen, Hua Min; Baltzell, Kimberly A. (20 December 2017). "Bovine leukemia virus linked to breast cancer but not co-infection with human papillomavirus: Case-control study of women in Texas". Cancer. doi:10.1002/cncr.31169.
- Zhang, Rong (10 October 2016). "Lack of association between bovine leukemia virus and breast cancer in Chinese patients". Breast Cancer Research. 18: 101. doi:10.1186/s13058-016-0763-8. PMC . PMID 27724949.
- Buehring, Gertrude C. (7 March 2017). "Response to "Lack of association between bovine leukemia virus and breast cancer in Chinese patients"". Breast Cancer Research. 19: 24. doi:10.1186/s13058-017-0808-7.
- Gillet, Nicolas A.; Willems, Luc (4 November 2016). "Whole genome sequencing of 51 breast cancers reveals that tumors are devoid of bovine leukemia virus DNA". Retrovirology. 13 (1). doi:10.1186/s12977-016-0308-3. PMC . PMID 27814725.
- Gutiérrez, Gerónimo; Rodríguez, Sabrina M.; de Brogniez, Alix; Gillet, Nicolas; Golime, Ramarao; Burny, Arsène; Jaworski, Juan-Pablo; Alvarez, Irene; Vagnoni, Lucas (2014-06-01). "Vaccination against δ-retroviruses: the bovine leukemia virus paradigm". Viruses. 6 (6): 2416–27. doi:10.3390/v6062416. PMC . PMID 24956179.
- Barez, Pierre-Yves; de Brogniez, Alix; Carpentier, Alexandre; Gazon, Hélène; Gillet, Nicolas; Gutiérrez, Gerónimo; Hamaidia, Malik; Jacques, Jean-Rock; Perike, Srikanth (2015-11-24). "Recent Advances in BLV Research". Viruses. 7 (11): 6080–8. doi:10.3390/v7112929. PMC . PMID 26610551.
- Kabeya H, Ohashi K, Onuma M (July 2001). "Host immune responses in the course of bovine leukemia virus infection". J. Vet. Med. Sci. 63 (7): 703–8. doi:10.1292/jvms.63.703. PMID 11503896.
- Gillet N, Florins A, Boxus M, et al. (2007). "Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human". Retrovirology. 4: 18. doi:10.1186/1742-4690-4-18. PMC . PMID 17362524.
- Takatori I, Itohara S, Yonaiyama K (1982). "Difficulty in detecting in vivo extracellular infective virus in cattle naturally infected with bovine leukemia virus". Leuk. Res. 6 (4): 511–7. doi:10.1016/0145-2126(82)90008-X. PMID 6292585.
- "Bovine leukemia virus". NCBI Taxonomy Browser. 11901.